[DPHARMA] YoY TTM Result on 31-Mar-2016 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Mar-2016 [#1]
Profit Trend
QoQ- -2.9%
YoY- 3.79%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 515,849 477,940 354,464 304,911 182,065 165,062 137,091 24.70%
PBT 65,197 52,929 32,714 47,508 47,513 42,396 35,384 10.71%
Tax -13,738 -9,746 -5,098 -9,864 -8,428 -7,243 -9,378 6.56%
NP 51,459 43,183 27,616 37,644 39,085 35,153 26,006 12.04%
-
NP to SH 51,459 43,710 27,890 37,659 36,283 35,153 26,006 12.04%
-
Tax Rate 21.07% 18.41% 15.58% 20.76% 17.74% 17.08% 26.50% -
Total Cost 464,390 434,757 326,848 267,267 142,980 129,909 111,085 26.90%
-
Net Worth 496,410 206,429 463,071 457,740 205,045 190,050 176,143 18.83%
Dividend
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Div 30,674 23,711 19,142 5,682 25,682 24,289 19,431 7.90%
Div Payout % 59.61% 54.25% 68.64% 15.09% 70.79% 69.10% 74.72% -
Equity
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Net Worth 496,410 206,429 463,071 457,740 205,045 190,050 176,143 18.83%
NOSH 661,881 278,959 278,959 278,959 139,486 138,723 138,695 29.73%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 9.98% 9.04% 7.79% 12.35% 21.47% 21.30% 18.97% -
ROE 10.37% 21.17% 6.02% 8.23% 17.70% 18.50% 14.76% -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
RPS 77.94 171.33 127.07 109.24 130.52 118.99 98.84 -3.88%
EPS 7.77 15.67 10.00 13.49 26.01 25.34 18.75 -13.64%
DPS 4.63 8.50 6.86 2.04 18.50 17.50 14.00 -16.83%
NAPS 0.75 0.74 1.66 1.64 1.47 1.37 1.27 -8.40%
Adjusted Per Share Value based on latest NOSH - 278,959
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
RPS 53.63 49.68 36.85 31.70 18.93 17.16 14.25 24.70%
EPS 5.35 4.54 2.90 3.91 3.77 3.65 2.70 12.06%
DPS 3.19 2.46 1.99 0.59 2.67 2.53 2.02 7.90%
NAPS 0.5161 0.2146 0.4814 0.4759 0.2132 0.1976 0.1831 18.84%
Price Multiplier on Financial Quarter End Date
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Date 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 -
Price 1.28 2.80 2.31 2.55 3.88 3.03 2.23 -
P/RPS 1.64 1.63 1.82 2.33 2.97 2.55 2.26 -5.20%
P/EPS 16.46 17.87 23.10 18.90 14.92 11.96 11.89 5.56%
EY 6.07 5.60 4.33 5.29 6.70 8.36 8.41 -5.28%
DY 3.62 3.04 2.97 0.80 4.77 5.78 6.28 -8.76%
P/NAPS 1.71 3.78 1.39 1.55 2.64 2.21 1.76 -0.47%
Price Multiplier on Announcement Date
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Date 21/05/19 28/05/18 22/05/17 18/05/16 18/05/15 20/05/14 27/05/13 -
Price 1.36 3.35 2.32 2.40 3.90 3.09 2.51 -
P/RPS 1.75 1.96 1.83 2.20 2.99 2.60 2.54 -6.01%
P/EPS 17.49 21.38 23.20 17.79 14.99 12.19 13.39 4.55%
EY 5.72 4.68 4.31 5.62 6.67 8.20 7.47 -4.34%
DY 3.41 2.54 2.96 0.85 4.74 5.66 5.58 -7.87%
P/NAPS 1.81 4.53 1.40 1.46 2.65 2.26 1.98 -1.48%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment